lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

The HIPPOCRATES Project: A Proof of Concept Promoting HCV Microelimination Strategy Plan in Prisons

21 Pages Posted: 16 Jan 2019

See all articles by Rui Gaspar

Rui Gaspar

Centro Hospitalar São João - Department of Gastroenterology and Hepatology

Rodrigo Liberal

Centro Hospitalar São João

Jorge Tavares

Estabelecimento Prisional do Porto

Rui Morgado

Estabelecimento Prisional do Porto

Guilherme Macedo

Estabelecimento Prisional do Porto

More...

Abstract

Background & Aims: In the last few years we have witnessed a revolution in the treatment of hepatitis C virus (HCV) infection. With the introduction of direct-acting antiviral agents (DAA), sustained virological response (SVR) is achieved in more than 95% of the patients. The focus is now being turned on to high-risk groups, with the aim of achieving HCV elimination by 2030. Prison inmates constitute one of the high-risk groups, and they receive treatment less frequently due to barriers in access to health care. The aim of this study is to describe the management and follow-up of a cohort of HCV monoinfected patients treated with DAA in the prison setting.

Methods: A prospective observational study was performed including all prison inmates monoinfected with HCV, from April 2017 to March 2018 in a Portuguese prison. Demographic, clinical and laboratorial data, as well as transient elastography measurements, were collected onsite by the medical team and prospectively recorded. Patients were treated with DAA according to international guidelines. SVR rates and adverse events were analyzed.

Results: 67 monoinfected HCV male inmates (mean age of 42,4 ±8,1 years) were enrolled. 72% reported history of injecting drugs or tattooing, with 44% of the latter being made in prison. 78% referred alcohol consumption of more than 30 g/day. The most prevalent genotype was 1a (54%), followed by 3 (30%) 4 (9%) and 1b (8%). Pretreatment fibrosis degree was mild-to-moderate (F0-F2) in 78% and severe in 22% (F3-F4). Treatment regimens chosen were: 52% elbasvir/grazoprevir, 30% sofosbuvir/velpatasvir and 18% sofosbuvir/ledispavir. No major adverse events were observed. SVR rate was 100%.

Conclusions: In a population considered hard-to-access and a cornerstone for HCV elimination, the doctors' visits to the prison setting, as well as the assisted medication administration lead to a 100% rate of SVR.

Funding Statement: The authors declare: "None."

Declaration of Interests: The authors declare: "None."

Ethics Approval Statement: This study was conducted according to the Declaration of Helsinki. The ethical approval for this study was obtained from the Ethics Committee of Centro Hospitalar São João and Porto's correctional system. Informed consent was obtained from each patient before each treatment.

Keywords: Hepatitis C infection; Treatment; Prison setting; direct-acting antiviral agents; microelimination

Suggested Citation

Gaspar, Rui and Liberal, Rodrigo and Tavares, Jorge and Morgado, Rui and Macedo, Guilherme, The HIPPOCRATES Project: A Proof of Concept Promoting HCV Microelimination Strategy Plan in Prisons (January 13, 2019). Available at SSRN: https://ssrn.com/abstract=3315832

Rui Gaspar (Contact Author)

Centro Hospitalar São João - Department of Gastroenterology and Hepatology ( email )

Porto, 4200-319
Portugal

Rodrigo Liberal

Centro Hospitalar São João

Porto
Portugal

Jorge Tavares

Estabelecimento Prisional do Porto

Porto
Portugal

Rui Morgado

Estabelecimento Prisional do Porto

Porto
Portugal

Guilherme Macedo

Estabelecimento Prisional do Porto

Porto
Portugal

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
27
PlumX Metrics
Downloads
5